Metraipolis › archive › dc_2e7bf4dda857

CAR-T Cell Therapy and Gut Microbiota Modulation in Multiple Sclerosis: Emerging Therapeutic Strategies and Current Limitations — Europe PMC PMID:42793314

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42793314
DOI
10.3390/cimb48090958
License (as archived)
solo-consultazione
Archived
2026-10-08T03:49:02.302Z
SHA-256 of the archived text
0a881e0f72ae38c8b4432dc69d975e0ad3a17df84560ac037b5ead4365a781bd
Stable URL of this page
https://metraipolis.com/documento/dc_2e7bf4dda857

How to cite

CAR-T Cell Therapy and Gut Microbiota Modulation in Multiple Sclerosis: Emerging Therapeutic Strategies and Current Limitations — Europe PMC PMID:42793314 — Europe PMC (en), https://europepmc.org/article/MED/42793314 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2e7bf4dda857 (Metraipolis archive dc_2e7bf4dda857, sha256 0a881e0f72ae38c8b4432dc69d975e0ad3a17df84560ac037b5ead4365a781bd)
BibTeX
@misc{dc2e7bf4dda857,
  title = {CAR-T Cell Therapy and Gut Microbiota Modulation in Multiple Sclerosis: Emerging Therapeutic Strategies and Current Limitations — Europe PMC PMID:42793314},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42793314},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2e7bf4dda857; sha256 0a881e0f72ae38c8b4432dc69d975e0ad3a17df84560ac037b5ead4365a781bd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42793314. Agents can read the archived copy with the MCP tool read_document.